Capreomycin Sulfate
- Capreomycin Sulfate
- 1405-37-4
- Capastat sulfate
- 215-776-8
- 9H8D3J7V21
- Capreomycin Sulfate
- 1405-37-4
- Capastat sulfate
- 215-776-8
- 9H8D3J7V21
- Ogostal
- CAPREOMYCIN SULFATE (MART.)
- CAPREOMYCIN SULFATE (USP IMPURITY)
- CAPREOMYCIN SULFATE (USP MONOGRAPH)
- CAPREOMYCIN SULPHATE
- CAPREOMYCIN, SULFATE (1:2) (SALT)
- CHEBI:3372
- NSC-755904
- SULFURIC ACID, COMPD. WITH CAPREOMYCIN (2:1)
98.071316 100
70.065179 19
127.097798 13.09
198.098521 8.73
69.044806 6.66
98.071267 100
507.205477 32.93
198.098380 32.65
265.104288 32.34
239.124958 20.63
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]
H332 (100%): Harmful if inhaled [Warning Acute toxicity, inhalation]
H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]
P203, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P318, P321, P330, P362+P364, P405, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 40 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Acute Tox. 4 (100%)
Acute Tox. 4 (100%)
Acute Tox. 4 (100%)
Repr. 1B (100%)
IMAP assessments - Capreomycin, sulfate (salt): Human health tier I assessment
IMAP assessments - Capreomycin, sulfate (salt): Environment tier I assessment
- PubChem
- Australian Industrial Chemicals Introduction Scheme (AICIS)Capreomycin, sulfate (salt)https://services.industrialchemicals.gov.au/search-assessments/
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/Capreomycin sulfatehttps://commonchemistry.cas.org/detail?cas_rn=1405-37-4
- ChemIDplusCapreomycin disulfatehttps://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0001405363Capreomycin sulfate [USAN:USP:JAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0001405374
- DTP/NCILICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuse
- EPA DSSTox3,6-Diamino-N-{[15-amino-3,6,9,12,16-pentahydroxy-8-({[hydroxy(imino)methyl]amino}methylidene)-11-(2-imino-1,3-diazinan-4-yl)-2-methyl-1,4,7,10,13-pentaazacyclohexadeca-3,6,9,12,16-pentaen-5-yl]methyl}hexanimidic acidhttps://comptox.epa.gov/dashboard/DTXSID90930862
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticeCapreomycin, sulfate (salt)https://echa.europa.eu/substance-information/-/substanceinfo/100.014.342Capreomycin, sulfate (salt) (EC: 215-776-8)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/85680
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingCAPREOMYCIN SULFATEhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/9H8D3J7V21
- Drugs@FDALICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingCAPREOMYCIN SULFATEhttps://www.accessdata.fda.gov/scripts/cder/daf/
- FDA Orange BookLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- MassBank of North America (MoNA)LICENSEThe content of the MoNA database is licensed under CC BY 4.0.https://mona.fiehnlab.ucdavis.edu/documentation/license
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuse
- Springer Nature